bone marrowderived progenitor cells mesenchymal stemcell Marker for CAF markers for activated CAF α SMA fibroblast specific protein FSP plateletderived ID: 935919
Download Presentation The PPT/PDF document "Origin of caf resident fibroblasts" is the property of its rightful owner. Permission is granted to download and print the materials on this web site for personal, non-commercial use only, and to display it on your personal computer provided you do not modify the materials and that you retain all copyright notices contained in the materials. By downloading content from our website, you accept the terms of this agreement.
Slide1
Slide2Origin of
caf
resident fibroblasts
bone
marrow-derived progenitor cells
,
mesenchymal
stemcell
....
Slide3Slide4Marker for CAF
markers
for activated
CAF:
α-
SMA,
fibroblast
specific protein (FSP
)
platelet-derived
growth factor (PDGF) receptors-
β
fibroblast
activation protein (FAP
)
Vimentin
Slide5Name of markers
Functions
α-
smooth muscle actin (
α-
SMA)
Marker for
myofibroblasts
[
Fibroblast activation protein
(FAP)
Marker for
myofibroblasts
Tenascin
-C
Regulates adhesion of cancer cells for
invasion
Periostin
Product of process of tissue
repair
Neuron glial antigen-2 (NG2)
More associated with pericytes. What fibroblasts come from
Vimentin
Plasma membrane associated
protein
Desmin
Marker for maturation of
microvessels
(to mark for
angiogenesis
Platelet derived growth factor receptor-α and β (PDGFR α and β)
Fibroblast specific protein-1 (FSP-1)- S100A4
Myofibroblasts
and fibroblasts make up
CAFs
Slide6FAP:
FAP is selectively expressed in CAFs and often used as a CAF marker
FAP
is originally identified as a membrane-bound serine protease implicated in extracellular matrix
remodeling.
FAP as a persistent activator of fibroblastic STAT3 through a
uPAR
-dependent FAK–
Src
–JAK2 signaling pathway
.
Promotes Immunosuppression by Cancer-Associated Fibroblasts in the Tumor Microenvironment via STAT3–CCL2
Signaling.
STAT3–CCL2
signaling in this setting promoted tumor growth by enhancing recruitment of myeloid-derived suppressor cells (MDSC
).
fibroblastic
CCL2 expression is under STAT3 control and causally linked to the ability of FAP-expressing CAFs to promote tumor growth and immunosuppressive microenvironment.
Slide7Desmin
:
expressed
in fibrotic tissue in wound healing and in tumor '
desmoplastic
'
stroma
.
angiogenic
signals,
pericytes
are recruited to developing endothelial tubes and express
desmin
in increasing amounts as they mature and elongate to form a stable sheath around the newly formed
vessels.
Alpha SMA:
Alpha-smooth muscle actin (
α-
SMA)
plays an important role in
fibrogenesis
.
Tenascin
:
as a member of
the extracellular matrix
plays
an important role in cancer cell proliferation and migration and tumor invasion in various types of cancer
Slide8Role of CAF
Tumor growth
Angiogenesis
Extra cellular matrix remodeling
Metastasis
Tumor invasion
chemoresistansis
Slide9Role of CAFs in cancer progression
ECM
remodelling
:
1-
collagen
: accumulation of type
I and III
collagens
Tumour
ECM stiffening
2-fibronectin:ligand for integrin receptor family including α5β1 receptor cell adhesion migration growth 3-hyaluronan:recruitment of tumour-associated macrophages
Slide10CAF
signalling
pathway
NFKB signaling
IL\stat3 signaling
TGFB\
smad
signaling
Foxo3a\VEGF\CCL2 signaling
And …
Slide11Secretion of soluble
factors :
HGF – EGF –
bFGF
– SDF1 – IL6 – IL8 – IL1B – IL10 – VEGFA –
TGFb
-PDGF
Cxcl2 - cxcl5 – cxcl8 – cxcl9 - cxcl10 – ccl7 – ccl20 – ccl26 – ccl2 – IDO – PGE2
HGF
:
activation
of the
c-Met pathway
in neighbouring cancer cells CAF-secreted HGF gives rise to an increased resistance of tumor cells to conventional tyroine kinase inhibitor against EGF receptorHGF secreted by CAFs enhanced the activation of uPA/uPAR
proteaseSDF1-IL8: cooperate in the
promotion of a complete angiogenic response in recruited
endothelial cells .CCL2: . CCL2 expression is associated with Th2 response.
CCL2-CCR2
signaling
recruit
myeloid cells such as TAMs to incite an
angiogenic
switch
and
myeloid-derived suppressor cells (MDSCs) to suppress and evade immune-mediated killing
Slide12Cxcl5:.
Downregulation
of CXCL5 could reduce cancer cell proliferation and migration through PI3K-AKT and ERK1/2 signaling
pathways.
Activation of the JAK/STAT pathway stimulates cell proliferation, differentiation, migration and apoptosis
.
STAT is also involved in vascular endothelial growth factor signaling and plays a pivotal role in
angiogenesis.
Cxcl8:
acts as
a multifunctional
cytokine to modulate
tumor proliferation, invasion and migration in an autocrine or paracrine mannerCCL20: CCL20 activated Akt, ERK1/2 pathwayActivated stress-activated protein kinase/c-Jun kinase MAPKs,increased interleukin-8 expression result: increase of cell migration increase
of cell proliferation
Slide13CXCL2:
.
powerful
neutrophil
chemoattractant
cancer metastasis
Angiogenesis
CXCL9\CXCL10:
.
CXCL9
, and CXCL10 can elicit antitumor
response accompanied with an enhanced infiltration of CD4+ and CD8+ lymphocytes.CXCL9/10/11, a regulator of PD-L1 expression in gastric cancer anti-angiogenic chemokines and they inhibit angiogenesis via the chemokine receptor CXCR3-B. These chemokines inhibit angiogenesis in colon carcinoma, melanoma and uterine cervical cancers .CCL7:. influence tumor migrationCCL7 activates the TGF-β pathway by enhancing Smad2 phosphorylation
CCL7 can enhance vascular permeability by recruiting TAMsCCL7 overexpression increases the recruitment of leukocytes and triggers type I T cell-dependent reactions
Slide14CAFs
secrete
several members of the MMP
direct degradation of
ECM, obviously associated with the generation of
space due
to
tumour
expansion, invasion or de novo
angiogenesis.
cleavage of membrane-bound growth factors or
cytokines as
well as their
receptors.cleavage of cell adhesion molecules like cadherins, leading to an increased motility and EMT.MMP-13 secreted by CAFs promotes tumour angiogenesis by releasing vascular endothelial growth factor (VEGF) from the ECM MMP-9, which in turn induces a clear EMT in prostate carcinoma cells, likely through E-cadherin negative regulation.